Elite Pharmaceuticals (ELTP) EV to FCF (2011 - 2026)
Elite Pharmaceuticals' (ELTP) EV to FCF came in at 20.49 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 51.4% from 42.15 a year earlier but up 30.8% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) EV to FCF (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EV to FCF at Elite Pharmaceuticals was 15.99, down 60.5% year-over-year; for FY2026 (ended Mar 31, 2026), it was 15.66, down 80.1% from FY2025.
- In prior fiscal years, Elite Pharmaceuticals' EV to FCF was 78.60 in FY2025 and 3.63 in FY2022 (-81.9%).
- Quarterly EV to FCF has run from a low of 3.63 in fiscal Q4 2022 to a high of 709.34 in fiscal Q2 2023 over five years.
- On a year-over-year basis, EV to FCF has declined in each of the last five quarters, with an average decline of 71.3% over the last five quarters.
- The strongest year-over-year quarter for EV to FCF in the past five years was fiscal Q1 2023, with growth of 14.4%; the weakest was fiscal Q4 2022, with a decline of 81.9%.
- According to Business Quant data, EV to FCF for the three prior fiscal quarters was 15.66 (Q4 2026), 29.36 (Q3 2026) and 30.50 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Elite Pharmaceuticals | 268.12 Mn | 149.80 Mn | 13.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.49 |
| Mar 31, 2026 | 15.66 |
| Dec 31, 2025 | 29.36 |
| Sep 30, 2025 | 30.50 |
| Jun 30, 2025 | 42.15 |
| Mar 31, 2025 | 78.60 |
| Dec 31, 2024 | 130.23 |
| Sep 30, 2024 | 133.88 |
| Jun 30, 2024 | 142.53 |
| Sep 30, 2022 | 709.34 |
| Jun 30, 2022 | 13.86 |
| Mar 31, 2022 | 3.63 |
| Dec 31, 2021 | 6.17 |
| Sep 30, 2021 | 18.28 |
| Jun 30, 2021 | 12.12 |
| Mar 31, 2021 | 20.03 |
| Dec 31, 2020 | 17.59 |
| Sep 30, 2020 | 62.35 |
| Sep 30, 2011 | 175.04 |
| Jun 30, 2011 | 40.35 |
API Access
Elite Pharmaceuticals EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();